Selective serotonin reuptake inhibitors: adverse effects, toxicity and interactions.
Mitchell
P B
PB
School of Psychiatry, University of New South Wales, Sydney, Australia.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003863:Depression / Q000188:drug therapy*; D004311:Double-Blind Method; D004347:Drug Interactions; D006801:Humans; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013574:Synaptosomes / Q000187:drug effects / Q000378:metabolism
D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors